![Stephen Biggar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Biggar
Presidente presso
ACADIA PHARMACEUTICALS INC.
Patrimonio netto: 2 M $ in data 31/05/2026
Profilo
Il Dr. Stephen R. Biggar è un amministratore indipendente di TScan Therapeutics, Inc., un amministratore indipendente di Kiniksa Pharmaceuticals Ltd. e un presidente di ACADIA Pharmaceuticals, Inc. Fa parte del consiglio di amministrazione di TScan Therapeutics, Inc., Kiniksa Pharmaceuticals Ltd. e Vivelix Pharmaceuticals, Ltd. Il Dr. Biggar è stato precedentemente impiegato come direttore indipendente presso Synageva BioPharma Corp. e partner di Baker Bros. Advisors LP. È stato anche membro del consiglio di amministrazione di BioCryst Pharmaceuticals, Inc. e Synageva BioPharma Corp. /Old/. Ha conseguito la laurea presso l'Università di Rochester, una laurea presso la Stanford University e un dottorato presso la Stanford University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 24/02/2026 | 61.541 ( 0,04% ) | 1 M $ | 31/05/2026 | |
0,03% | 06/04/2026 | 12.546 ( 0,03% ) | 606 975 $ | 31/05/2026 |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Posizioni attive di Stephen Biggar
| Società | Posizione | Inizio |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Presidente | 10/06/2016 |
| TSCAN THERAPEUTICS, INC. | Presidente | 12/06/2024 |
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Direttore/Membro del Consiglio | 01/10/2015 |
Notch Therapeutics, Inc.
 Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops cell therapies for the treatment of diseases | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Stephen Biggar
| Società | Posizione | Fine |
|---|---|---|
| SYNAGEVA BIOPHARMA CORP | Direttore/Membro del Consiglio | 22/06/2015 |
Synageva BioPharma Corp. /Old/
 Synageva BioPharma Corp. /Old/ BiotechnologyHealth Technology Manufactures biopharmaceutical products | Direttore/Membro del Consiglio | 04/11/2011 |
| BIOCRYST PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 10/10/2011 |
Vivelix Pharmaceuticals, Ltd.
 Vivelix Pharmaceuticals, Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Direttore/Membro del Consiglio | - |
Formazione di Stephen Biggar
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
61
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Baker Bros. Advisors LP
 Baker Bros. Advisors LP Investment ManagersFinance BBA pursues a fundamentally driven approach to life sciences investing. The firm typically takes large, concentrated positions in the securities of life sciences companies with the potential for significant value creation over the long-term. They focus on public securities, but may, from time to time, recommend investments in private companies, life sciences and related healthcare intellectual property, royalty streams or other non-public investment opportunities. | Finance |
Synageva BioPharma Corp. /Old/
Synageva BioPharma Corp. /Old/ BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
Vivelix Pharmaceuticals, Ltd.
Vivelix Pharmaceuticals, Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
TScan Therapeutics, Inc.
 TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
Notch Therapeutics, Inc.
Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops cell therapies for the treatment of diseases | Health Technology |
